Top Stories

Able Medical Announces First Surgeries and Launch of the Valkyrie™ Thoracic Fixation System

June 9, 2021

MARQUETTE, Mich.–(BUSINESS WIRE)–Able Medical Devices announces the recent launch of its Valkyrie™ Thoracic Fixation System, the market’s first single-use radiolucent plating system designed to span the osteotomy and close the sternum after open heart surgery.

The system’s unique material properties allow the implant to be contoured in-situ which saves time and improves efficiency in the operating room by reducing procedural steps.

“The Valkyrie system conforms directly to a patient’s anatomy making it a custom fit with minimal manipulation,” said Dr. Vitaly Piluiko, chief of cardiothoracic surgery for Mountain View Regional Medical Center in Las Cruces, NM. “The entire procedure was easier and faster while the plates themselves added the benefit of radiolucency and the screws inserted without fear of cross threading.”

The Valkyrie system enhances the company’s groundbreaking material science platform by simplifying the procedure and providing a hydroxyapatite nano-thin surface treatment to its screws. This novel application improves pullout strength and has been shown to increase bone density by 123% compared to traditional screws.

“The screw is the first of its kind to offer this level of advanced bony integration, and the system has been overwhelmingly accepted at all our initial Centers of Excellence,” said Peter Didyk, managing director of Able. “The momentum and excitement from the field has been overwhelming, and we look forward to helping as many patients as possible.”

Valkyrie is intended for use in the stabilization and fixation of fractures of the chest wall, including sternal fixation following sternotomy, as well as sternal reconstructive surgical procedures for patients with normal and/or poor bone.

About Able Medical Devices

Able Medical Devices is a subsidiary of J.M. Longyear and a leader in cardiothoracic products and contract manufacturing. Able partners with companies seeking first class, outsourced services from design & development to comprehensive finished goods manufacturing. The company’s extensive expertise includes working with surgeons and OEMs in spine, trauma and cardiothoracic markets. Able specializes in developing full surgical systems as well as custom instrumentation.

For more information, see


Russ Stechow
Product Manager – Cardiothoracic
M: 586.876.4196

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button